Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Kymera Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −6 vs. Q3 2022
- Shares held
- 56.1M
- +3.76M (+7.2%) vs. Q3 2022
- Total value
- $1.40B
- +$261.1M (+22.9%) vs. Q3 2022
- New holders
- 16
- 48 more added
- Sold out
- 22
- 38 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 551,523 | $13.8M | 0.00% | −10,349−1.8% | Reduced |
| Deer Management Co. LLC | 615,895 | $15.4M | 1.42% | 00.0% | Unchanged |
| Aquilo Capital Management, LLC | 629,411 | $15.7M | 6.99% | +299,165+90.6% | Added |
| Geode Capital Management, LLC | 747,071 | $18.6M | 0.00% | +45,849+6.5% | Added |
| EcoR1 Capital, LLC | 796,093 | $19.9M | 0.61% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 832,221 | $20.8M | 0.14% | −228,340−21.5% | Reduced |
| FMR LLC | 846,046 | $21.1M | 0.00% | +520,360+159.8% | Added |
| Bank of New York Mellon Corp | 989,966 | $24.7M | 0.01% | −35,278−3.4% | Reduced |
| Rock Springs Capital Management LP | 1,227,779 | $30.6M | 0.74% | +181,036+17.3% | Added |
| T. Rowe Price Investment Management, Inc. | 1,955,977 | $48.8M | 0.04% | −40,552−2.0% | Reduced |
| Artal Group S.A. | 2,000,000 | $49.9M | 2.88% | +500,000+33.3% | Added |
| Redmile Group, LLC | 2,673,837 | $66.7M | 2.73% | −202,800−7.0% | Reduced |
| State Street Corp | 2,846,221 | $71.0M | 0.00% | +160,817+6.0% | Added |
| Baker Bros. Advisors LP | 2,879,825 | $71.9M | 0.43% | 00.0% | Unchanged |
| BlackRock Inc. | 3,334,901 | $83.2M | 0.00% | +130,219+4.1% | Added |
| Vanguard Group Inc | 3,660,307 | $91.4M | 0.00% | +797,130+27.8% | Added |
| Avoro Capital Advisors LLC | 3,850,000 | $96.1M | 1.44% | +1,680,770+77.5% | Added |
| Price T Rowe Associates Inc | 4,379,159 | $109.3M | 0.02% | +281,447+6.9% | Added |
| Wellington Management Group LLP | 4,591,089 | $114.6M | 0.02% | +1,180,703+34.6% | Added |
| BVF Inc | 4,692,604 | $117.1M | 4.94% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149.4M | 17.99% | −890,962−13.0% | Reduced |
| Pictet Asset Management SA | 0 | $0 | 0.00% | −482,001−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −101,001−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −75,804−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −69,085−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −47,468−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,943−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −26,550−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −25,480−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −25,031−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −21,552−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −19,076−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −13,379−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,256−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −11,520−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,921−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,629−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −6,770−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −6,589−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,922−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | 0 | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −267−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| AJU IB Investment Co., Ltd. | – | – | – | – | Not filed |